Lipid composition of serum lipoproteins in patients with primary type IIb and type IV hyperlipoproteinemia

      This paper is only available as a PDF. To read, Please Download here.


      Cholesterol, triglyceride and phospholipid concentrations of VLDL, LDL and HDL were studied in 20 patients with primary type IIb, 25 patients with primary type IV and in 18 controls. Both types are not only characterized by different concentrations of lipoprotein lipids, but also by their different lipid composition. Type IIb had more triglycerides in the LDL, type IV in the LDL and HDL. The HDL cholesterol content of type IV was decreased. The percent phospholipid concentration of HDL was identical in the 3 groups, demonstrating the constant role of this lipid fraction. The lipid relationships between the lipoproteins showed that the LDL/HDL lipid ratio of type IIb exceeded type IV ratio in spite of normal HDL lipid concentration in type IIb.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Carlson L.A.
        The effect of nicotinic acid treatment on the chemical composition of plasma lipoprotein classes in man.
        Adv. Exp. Med. Biol. 1969; 4: 327
        • Schonfeld G.
        • Birge C.
        • Miller J.P.
        • Kessler G.
        • Santiago J.
        Apolipoprotein B levels and altered lipoprotein composition in diabetes.
        Diabetes. 1974; 23: 827
        • Carlson L.A.
        • Olsson A.G.
        • Orö L.
        • Rössner S.
        • Walldius G.
        Effects of hypolipidemic regimes on serum lipoproteins.
        in: 3rd edition. Atherosclerosis. III. Springer, Berlin1974: 768
        • Vessby B.
        • Lithell H.
        Dietary effects on lipoprotein levels in hyperlipoproteinemia — Delineation of two subgroups of endogenous hypertriglyceridemia.
        Artery. 1974; 1: 63
        • Olsson A.G.
        • Orö L.
        • Rössner S.
        Dose-response effect of single and combined clofibrate (Atromid®) and niceritrol (Perycit®) treatment on serum lipids and lipoproteins in type II hyperlipoproteinemia.
        Atherosclerosis. 1975; 22: 91
        • Witztum J.L.
        • Schonfeld G.
        • Weidman S.W.
        The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
        J. Lab. Clin. Med. 1976; 88: 1008
        • Vessby B.
        • Hedstrand H.
        • Olsson U.
        Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinemia.
        Uppsala J. Med. Sci. 1976; 81: 71
        • Vessby B.
        Studies on the serum lipoprotein composition in 50-year-old men — A suggestion of chemical criteria for diagnosis of hyperlipoproteinemia type III (broad-β-disease).
        Clin. Chim. Acta. 1976; 69: 29
        • Vessby B.
        • Lithell H.
        • Boberg J.
        Supplementation with vitamin E in hyperlipedemic patients treated with diet and clofibrate — Effects on serum lipoprotein concentrations, plasma fatty acid composition and adipose tissue lipoprotein lipase activity.
        Amer. J. Clin. Nutr. 1977; 30: 517
        • Gyntelberg F.
        • Brennan R.
        • Holloszy J.O.
        • Schonfeld G.
        • Rennie M.J.
        • Weidman S.W.
        Plasma triglyceride lowering by exercise despite increased food intake in patients with type IV hyperlipoproteinemia.
        Amer. J. Clin. Nutr. 1977; 30: 716
        • Weisweiler P.
        • Schwandt P.
        Lipoproteinveränderungen unter Clofibrat bei Typ IV-Hyperlipoproteinämien.
        Klin. Wschr. 1977; 55: 791
        • Havel R.J.
        • Eder H.A.
        • Bragdon J.H.
        The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.
        J. Clin. Invest. 1955; 34: 1345
        • Eggstein M.
        • Kreutz F.H.
        Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe.
        Klin. Wschr. 1966; 44: 262
        • Röschlau P.
        • Bernt E.
        • Gruber W.
        Enzymatische Bestimmung des Gesamtcholesterins im Serum.
        Z. Klin. Chem. 1974; 12: 403
        • Fiske C.H.
        • Subbarow Y.
        The colorimetric determination of phosphorus.
        J. Biol. Chem. 1925; 66: 375
        • Seidel D.
        • Wieland H.
        • Ruppert C.
        Improved techniques for assessment of plasma lipoprotein patterns, Part 1 (Precipitation in gels after electrophoresis with the polyanionic compounds).
        Clin. Chem. 1973; 19: 737
        • Beaumount J.-L.
        • Carlson L.A.
        • Cooper G.R.
        • Fejfar Z.
        • Fredrickson D.S.
        • Strasser T.
        Classification of hyperlipidemias.
        Bull. Wld. Hlth. Org. 1970; 43: 891
        • Eisenberg S.
        Lipoprotein metabolism and hyperlipemia.
        in: 3rd edition. Atherosclerosis Reviews. Vol. 1. Raven Press, New York1976: 23
        • Warth M.R.
        • Arky R.A.
        • Knopp R.H.
        Lipid metabolism in pregnancy, Part 3 (Altered lipid composition in intermediate, very low, low and high-density lipoprotein fractions.
        J. Clin. Endocrinol. Metab. 1975; 41: 649
        • Carlson L.A.
        • Ericsson M.
        Quantitative and qualitative serum lipoprotein analysis, Part 2 (Studies a male survivors of myocardial infarction).
        Atherosclerosis. 1975; 21: 435
        • Miller G.J.
        • Miller N.E.
        Plasma high density lipoprotein concentration and development of ischaemic heart disease.
        Lancet. 1975; 1: 16